Changmao Biochemical Engineering Co. Ltd. Class H (HK:0954) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Changmao Biochemical Engineering Co. Ltd. successfully held its Annual General Meeting (AGM) on May 28, 2024, with unanimous approval of all proposed resolutions by attending shareholders. Key resolutions included the adoption of audited financial statements, the 2023 Working Reports of the Board and Supervisory Committee, and the reappointment of PricewaterhouseCoopers as auditors. The 333,596,000 shares represented at the AGM voted 100% in favor of each resolution, indicative of strong shareholder support.
For further insights into HK:0954 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money